Senior insider sale
Chief Executive Officer at CRESCENT BIOPHARMA, INC. — senior position signals high conviction
$794.6K
44.08K shares
What this filing means
BRUMM JOSHUA T plans to sell 44.08K shares of CRESCENT BIOPHARMA, INC. valued at approximately $794.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001628280-26-062211
DirectorOfficer· Chief Executive Officer
Since Jun 2025
44.08K
Shares to sell
$794.6K
Approx. market value
3.44K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Services rendered
9/15/2026
3.44KTotal acquired3.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Restricted Stock Unit Vesting Services rendered | 3.44K | — |
| Total | 3.44K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
42.30K
Market value
$761.3K
6/22/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.77K
Market value
$33.3K
9/16/2026
Total
Units
44.08K
Value
$794.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 42.30K | $761.3K | — | Completed |
| Planned — Approximate Date | ||||
9/16/2026 | 1.77K | $33.3K | Nasdaq | Planned |
| Total | 44.08K | $794.6K | ||